Protalix BioTherapeutics (PLX) EBIT (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
6,393.45% |
| Dec 31, 2025 |
-115.77% |
| Sep 30, 2025 |
81.83% |
| Jun 30, 2025 |
128.28% |
| Mar 31, 2025 |
-157.50% |
| Dec 31, 2024 |
80.63% |
| Sep 30, 2024 |
264.44% |
| Jun 30, 2024 |
50.02% |
| Mar 31, 2024 |
13.52% |
| Dec 31, 2023 |
-197.56% |
| Sep 30, 2023 |
-109.24% |
| Jun 30, 2023 |
930.46% |
| Mar 31, 2023 |
-132.80% |
| Dec 31, 2022 |
339.87% |
| Sep 30, 2022 |
43.43% |
| Jun 30, 2022 |
-195.40% |
| Mar 31, 2022 |
67.23% |
| Dec 31, 2021 |
-202.71% |
| Sep 30, 2021 |
79.43% |
| Jun 30, 2021 |
-147.40% |
